Orchid Bioscience, Inc. to change its name to Orchid Cellmark Inc.
Orchid BioSciences, Inc. announced that its stockholders approved a proposal to change the company's name to Orchid Cellmark Inc. The proposal was approved at Orchid's annual meeting of stockholders. The name change to Orchid Cellmark Inc. will become effective on June 15, 2005. Orchid's shares will continue to trade on the Nasdaq National Market under the symbol "ORCH".
"Since 1987 the Cellmark brand has been associated with innovation and leadership in identity DNA testing in both the U.S. and U.K., so we believe that the name Orchid Cellmark more accurately reflects our current status and strong focus on being a leading provider of genetic profile information worldwide," said Paul J. Kelly, M.D., president and chief executive officer of Orchid. "The Cellmark name is well-recognized in the criminal justice community, reflecting Cellmark's almost two decades of pioneering work in forensic DNA testing, and we have built on and extended that brand equity in our family relationship and agriculture service lines. We look forward to continuing to grow our business globally under the Orchid Cellmark brand as identity DNA testing is increasingly used for forensic, parentage, immigration, adoption, security, food safety and other important applications."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
